These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34325681)

  • 21. Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada.
    Nassau T; Kolla G; Mason K; Hopkins S; Tookey P; McLean E; Werb D; Scheim A
    Harm Reduct J; 2022 Mar; 19(1):33. PubMed ID: 35351160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences.
    Pijl E; Oosterbroek T; Motz T; Mason E; Hamilton K
    Harm Reduct J; 2021 Jan; 18(1):5. PubMed ID: 33407575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of Harm Reduction Kits in a Specialty HIV Hospital.
    Miskovic M; Chan Carusone S; Guta A; O'Leary B; dePrinse K; Strike C
    Am J Public Health; 2018 Oct; 108(10):1363-1365. PubMed ID: 30138074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility desires of people living with HIV: does the implementation of a sexual and reproductive health and HIV integration model change healthcare providers' attitudes and clients' desires?
    Milford C; Beksinska M; Greener R; Pienaar J; Rambally Greener L; Mabude Z; Smit J
    BMC Health Serv Res; 2021 May; 21(1):509. PubMed ID: 34039312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV/AIDS: a qualitative study.
    McNeil R; Dilley LB; Guirguis-Younger M; Hwang SW; Small W
    J Int AIDS Soc; 2014; 17(1):18855. PubMed ID: 24629844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study.
    Kesten J; Hussey D; Lord C; Roberts L; Bayliss J; Erswell H; Preston A; Telfer M; Scott J; Harris M; Mellon D; Hickman M; MacArthur G; Fisher H
    Harm Reduct J; 2023 Aug; 20(1):114. PubMed ID: 37608267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
    Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
    Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
    Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
    Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supervised injection services: what has been demonstrated? A systematic literature review.
    Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
    Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.
    Enns EA; Zaric GS; Strike CJ; Jairam JA; Kolla G; Bayoumi AM
    Addiction; 2016 Mar; 111(3):475-89. PubMed ID: 26616368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "And if my goal is never to leave Casey House?": The significance of place attachment for patients at a specialty HIV hospital in Toronto, Canada.
    Rudzinski K; King K; Guta A; Chan Carusone S; Strike C
    Health Place; 2023 Sep; 83():103100. PubMed ID: 37595542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internet-based HIV and sexually transmitted infection testing in British Columbia, Canada: opinions and expectations of prospective clients.
    Hottes TS; Farrell J; Bondyra M; Haag D; Shoveller J; Gilbert M
    J Med Internet Res; 2012 Mar; 14(2):e41. PubMed ID: 22394997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
    Carnes NA; Asher AK; Bohm MK; Bessler PA
    Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for integrating physiotherapy into an interprofessional outpatient care setting for people living with HIV: a qualitative study.
    deBoer H; Cudd S; Andrews M; Leung E; Petrie A; Chan Carusone S; O'Brien KK
    BMJ Open; 2019 May; 9(5):e026827. PubMed ID: 31129584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial.
    Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP
    J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.